Rapid maxillary expansion (RME) is used to correct transverse deficiencies of the maxilla. This randomized controlled trial compares three RME devices in adolescents (age 10-15) with at least 8 mm maxillary transverse deficiency: (1) bone-borne expander supported by two palatal miniscrews, (2) bone-borne expander supported by four palatal miniscrews, and (3) conventional tooth-borne Hyrax expander. Devices were placed using static computer-guided miniscrew insertion (where applicable). All participants received the same activation protocol to reach 8 mm expansion. Cone-beam CT scans were obtained pre-treatment (T0) and at 6 months post-treatment (T1). The trial assesses skeletal, dentoalveolar, periodontal, and nasal/airway outcomes. Enrollment: 36 subjects. Study sites: Sapienza University of Rome.
This is a prospective, randomized, parallel-group clinical trial performed at the Department of Oral and Maxillofacial Sciences, Sapienza University of Rome (Nov 2021 - Sep 2024). Inclusion criteria included age under 16 years, late mixed or permanent dentition, and maxillary transverse deficiency ≥ 8 mm. Exclusion: poor oral hygiene; previous orthodontic treatment; craniofacial syndromes; cleft lip/palate; genetic/congenital diseases. After consent, eligible participants (N=36) were randomized (1:1:1) to: Group A - two-miniscrew bone-borne expander (paramedian screws near 1st-2nd premolar region); Group B - four-miniscrew bone-borne expander (two paramedian + two parapalatine); Group C - Hyrax tooth-borne expander banded to upper first molars. Miniscrews (Benefit system; PSM Medical Solutions) were placed using a CAD-CAM surgical guide planned from CBCT and digital models (Easy Driver). Activation: Hyrax click 10 mm screw; four quarter-turns at insertion then three quarter-turns/day for 12 days (0.20 mm/turn; \~0.6 mm/day) until 8 mm achieved. CBCT scan acquisition: Scanora 3Dx (Soredex). Measurements performed on Simplant v17 on defined landmarks (MaxBas, MaxAlv, MaxAlvPre, Ns, ZigMax, IntermCo, IntermoAp, molar angles, periodontal bone thickness measures, nasopalatine foramen width). Primary outcome: change in maxillary basal width (MaxBas) T0 to T1 measured on CBCT.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
36
Two palatal miniscrews with custom bone-borne expansion framework (device transmits forces to palatal bone; no tooth bands).
Four palatal miniscrews with custom bone-borne expansion appliances.
Hyrax-type tooth-borne expander with bands cemented on upper first molars (Hyrax click 10 mm).
Sapienza University of Rome
Rome, Rm, Italy
Change in maxillary basal width (MaxBas) from baseline (T0) to 6 months post-treatment (T1)
Measurement method: CBCT (Simplant software) distance between alveolar/basal points (points 5-6 as per Podesser/Garib protocol).
Time frame: at 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.